InvestorsHub Logo
Followers 6
Posts 322
Boards Moderated 0
Alias Born 02/17/2015

Re: 2014shelby post# 30601

Tuesday, 03/15/2016 10:41:42 AM

Tuesday, March 15, 2016 10:41:42 AM

Post# of 54983
Now that Epidiolex (GW Pharma’s drug)  reached it’s endpoint, there is statistical evidence that Cbd helps mitigate seizures.  There are several “Cbd” companies that can benefit, but only one has the ability to upregulate and downregulate cannabinoids, 22ndCentury Group, XXII (http://www.xxiicentury.com/our-cannabis-hemp-technology). ; The company’s partner, Anandia Labs (http://www.anandialabs.com), is a major player in the Cannabis market in Canada, and with this new momentum in the space, i think the stock can do well from here as it is currently not on anyone’s radar in the CBD/medical marijuana sector. IMO

 

http://finance.yahoo.com/news/22nd-century-announces-cannabis-research-115000129.html

 

http://seekingalpha.com/article/2112493-is-22nd-century-group-seeded-for-growth

 

http://seekingalpha.com/article/2505215-the-purest-play-in-the-cannabis-wave-and-it-trades-on-the-nyse?uprof=42
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XXII News